AU Patent

AU2008323561B2 — Inhibitors of human immunodeficiency virus replication

Assigned to Gilead Sciences Inc · Expires 2013-07-18 · 13y expired

What this patent protects

The present invention relates to compounds of formula (I) wherein c, X, Y, R

USPTO Abstract

The present invention relates to compounds of formula (I) wherein c, X, Y, R

Drugs covered by this patent

cabotegravir-sodium (CABOTEGRAVIR SODIUM)

Patent Metadata

Patent number: AU2008323561B2
Jurisdiction: AU
Classification: —
Expires: 2013-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.